GeneKey Offers New Hope to Cancer Patients on “Moving America Forward” Hosted by William Shatner
William Shatner discovers how Genekey has started a revolution known as personalized medicine which may be one of the most promising breakthroughs in cancer treatment.
FOR IMMEDIATE RELEASE
PRLog (Press Release) - Aug. 14, 2013 - LOS ANGELESE, Calif. -- This year, one million Americans will learn they have cancer. Roughly two out of three cancer patients will die of the illness (or related therapy) within five years of diagnosis. We are at the beginning of a pivotal chapter in the history of medicine and GeneKey’s unique approach, based on analysis of a patient’s cancer cells vs. their normal cells across multiple full-genome technologies, has put them in the forefront of the field. GeneKey’s CSO Dr. Raphael Lehrer explained to Mr. Shatner that “Today’s patients can’t wait for tomorrow’s scientific discoveries”, by using multiple technologies in addition to full genome sequencing, Genekey is able to make more biological connections leading to an extraordinary rate of finding treatment strategies”. With a philosophy that every cancer is unique and every treatment should be too, for 95% of patients participating in GeneKey’s program, they are able to identify new therapeutic approaches.
Watch William Shatner & Doug Lleweyln’s Interview with GeneKey and find out how they have personalized cancer treatment: